Skip to main content

Table 3 Treatment regimens

From: High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis

Treatment regimen No. (%)
Longer treatment regimen 198 (93.0)
 SLI + FQ + Eto + Cs + Z/FQ + Eto + Cs + Z 68 (31.9)
 SLI + FQ + Eto + Cs + PAS + Z/FQ + Eto + Cs + PAS + Z 55 (25.8)
 SLI + FQ + Eto + Cs + Z + E/FQ + Eto + Cs + Z + E 30 (14.1)
 SLI + FQ + Eto + Cs + PAS + Z + E/FQ + Eto + Cs + PAS + Z + E 10 (4.7)
 Othersa 35 (16.4)
Shorter treatment regimen 15 (7.0)
 Am + Z + FQ + Eto + Cfz + high dose H + E/Z + FQ + Cfz + E 15 (7.0)
  1. Cs cycloserine, E ethambutol, Eto ethionamide, FQ fluoroquinolones, Km kanamycin, PAS para-amino salicylic acid, SLI second-line injectable (amikacin/kanamycin/capreomycin), Z pyrazinamide
  2. aGiven in Additional file 1: Table S1